Sex-associated molecular differences for cancer immunotherapy

Immune checkpoint blockade therapies have extended patient survival across multiple cancer lineages, but there is a heated debate on whether cancer immunotherapy efficacy is different between male and female patients. We summarize the existing meta-analysis to show inconsistent conclusions for wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Youqiong, Jing, Ying, Li, Liang, Mills, Gordon B., Diao, Lixia, Liu, Hong, Han, Leng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156379/
https://www.ncbi.nlm.nih.gov/pubmed/32286310
http://dx.doi.org/10.1038/s41467-020-15679-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156379/
https://www.ncbi.nlm.nih.gov/pubmed/32286310
http://dx.doi.org/10.1038/s41467-020-15679-x

Ejemplares similares